| Literature DB >> 26042034 |
Silvia Serino1, Francesca Morganti2, Fabio Di Stefano3, Giuseppe Riva4.
Abstract
Several studies have pointed out that egocentric and allocentric spatial impairments are one of the earliest manifestations of Alzheimer's Disease (AD). It is less clear how a break in the continuous interaction between these two representations may be a crucial marker to detect patients who are at risk to develop dementia. The main objective of this study is to compare the performances of participants suffering from amnestic mild cognitive impairment (aMCI group), patients with AD (AD group) and a control group (CG), using a virtual reality (VR)-based procedure for assessing the abilities in encoding, storing and syncing different spatial representations. In the first task, participants were required to indicate on a real map the position of the object they had memorized, while in the second task they were invited to retrieve its position from an empty version of the same virtual room, starting from a different position. The entire procedure was repeated across three different trials, depending on the object location in the encoding phase. Our finding showed that aMCI patients performed significantly more poorly in the third trial of the first task, showing a deficit in the ability to encode and store an allocentric viewpoint independent representation. On the other hand, AD patients performed significantly more poorly when compared to the CG in the second task, indicating a specific impairment in storing an allocentric viewpoint independent representation and then syncing it with the allocentric viewpoint dependent representation. Furthermore, data suggested that these impairments are not a product of generalized cognitive decline or of general decay in spatial abilities, but instead may reflect a selective deficit in the spatial organization Overall, these findings provide an initial insight into the cognitive underpinnings of amnestic impairment in aMCI and AD patient exploiting the potentiality of VR.Entities:
Keywords: Alzheimer’s disease; allocentric representation; egocentric representation; mild cognitive impairment; virtual reality
Year: 2015 PMID: 26042034 PMCID: PMC4438252 DOI: 10.3389/fnagi.2015.00088
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.750
Demographic and clinical information.
| Group | |||
|---|---|---|---|
| Test or variable | aMCI group1 | AD group1 | CG1 |
| Male | 11 | 11 | 9 |
| Years of age2 | 77.53 (5.52) | 82.93 (5.61) | 73.87 (7.38) |
| Years of education2 | 7.73 (4.48) | 6.60 (3.83) | 12.27 (3.88) |
| Duration of disease (months)2 | – | 25.62 (10.45) | – |
| MMSE2,3 | 22.46 (1.95) | 23.06 (1.50) | 27.52 (1.48) |
Analysis of variance results of mean scores obtained by participants divided into the three groups at the spatial neuropsychological tests.
| Group | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| aMCI group1 | AD group1 | CG1 | aMCI group1 vs. AD group1 | aMCI group1 vs. CG1 | CG1 vs. AD group1 | ||||
| Corsi Block Test- Span2 | 4.73 (0.50) | 4.38 (0.83) | 5.16 (0.62) | 5.17 | ∗∗ | 0.198 | N.S. | N.S | ∗∗ |
| Corsi Block Test- Supraspan2 | 7.96 (3.77) | 5.54 (2.32) | 13.33 (5.86) | 13.13 | ∗∗∗ | 0.391 | N.S. | ∗∗ | ∗∗∗ |
| Money Rood Map2 | 16.73 (5.63) | 16.80 (3.09) | 21.20 (6.59) | 3.48 | ∗ | 0.142 | N.S. | N.S. | ∗∗ |
| Manikin’s Test2 | 23.13 (6.63) | 17.07 (3.05) | 28.73 (3.55) | 23.42 | ∗∗∗ | 0.527 | ∗∗ | ∗∗ | ∗∗∗ |
| Judgment of Line Orientation2 | 16.57 (7.77) | 6.33 (5.46) | 21.73 (3.82) | 26.79 | ∗∗∗ | 0.567 | ∗ | ∗∗∗ | ∗∗∗ |
Mean scores obtained by participants divided into the three groups at the virtual-reality based procedure for evaluating abilities in encoding, using and syncing spatial representations.
| Task | Trial | Mean | SD | |
|---|---|---|---|---|
| aMCI group1 | Task 1 | First trial | 3.89 | 0.01 |
| Task 1 | Second trial | 3.86 | 0.36 | |
| Task 1 | Third trial | 2.57 | 0.93 | |
| Task 2 | First trial | 3.13 | 0.51 | |
| Task 2 | Second trial | 2.93 | 0.79 | |
| Task 2 | Third trial | 2.07 | 0.96 | |
| AD group1 | Task 1 | First trial | 3.53 | 0.73 |
| Task 1 | Second trial | 3.87 | 0.51 | |
| Task 1 | Third trial | 2.93 | 1.03 | |
| Task 2 | First trial | 3.13 | 0.51 | |
| Task 2 | Second trial | 2.93 | 0.79 | |
| Task 2 | Third trial | 2.07 | 0.96 | |
| CG1 | Task 1 | First trial | 3.73 | 1.03 |
| Task 1 | Second trial | 3.73 | 0.45 | |
| Task 1 | Third trial | 3.60 | 0.82 | |
| Task 2 | First trial | 3.33 | 1.11 | |
| Task 2 | Second trial | 3.60 | 0.50 | |
| Task 2 | Third trial | 3.07 | 1.43 |